National Health Investors (NYSE:NHI) Sets New 1-Year High at $63.42

National Health Investors, Inc. (NYSE:NHI - Get Free Report)'s stock price hit a new 52-week high during trading on Monday . The stock traded as high as $63.42 and last traded at $63.40, with a volume of 2283 shares trading hands. The stock had previously closed at $62.89.

Analyst Upgrades and Downgrades

NHI has been the subject of several recent analyst reports. BMO Capital Markets upgraded National Health Investors from a "market perform" rating to an "outperform" rating and set a $67.00 target price for the company in a research report on Tuesday, March 12th. Wells Fargo & Company upgraded shares of National Health Investors from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $55.00 to $63.00 in a research report on Monday, February 26th. Wedbush lifted their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an "outperform" rating in a research report on Monday, March 18th. Deutsche Bank Aktiengesellschaft started coverage on shares of National Health Investors in a report on Tuesday, January 30th. They issued a "buy" rating and a $69.00 price target on the stock. Finally, StockNews.com downgraded shares of National Health Investors from a "buy" rating to a "hold" rating in a report on Thursday, April 18th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $60.50.

National Health Investors Stock Down 0.2 %

The company has a market capitalization of $2.73 billion, a P/E ratio of 20.05 and a beta of 0.95. The company has a 50-day moving average of $59.94 and a two-hundred day moving average of $55.86. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Thursday, March 28th will be given a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.74%. National Health Investors's dividend payout ratio is currently 115.02%.

Insider Buying and Selling at National Health Investors

In other news, Director Charlotte A. Swafford purchased 10,000 shares of the company's stock in a transaction that occurred on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the purchase, the director now directly owns 110,185 shares in the company, valued at approximately $6,466,757.65. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 7.26% of the stock is owned by company insiders.

Institutional Trading of National Health Investors

Institutional investors have recently made changes to their positions in the stock. Equitable Trust Co. purchased a new position in National Health Investors in the first quarter worth about $310,000. Albert D Mason Inc. bought a new position in shares of National Health Investors in the 1st quarter worth approximately $213,000. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of National Health Investors by 9.9% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 407,855 shares of the real estate investment trust's stock worth $25,626,000 after buying an additional 36,653 shares during the last quarter. Allspring Global Investments Holdings LLC grew its position in National Health Investors by 66.2% during the first quarter. Allspring Global Investments Holdings LLC now owns 2,594 shares of the real estate investment trust's stock valued at $163,000 after buying an additional 1,033 shares during the period. Finally, DGS Capital Management LLC purchased a new stake in National Health Investors during the first quarter valued at approximately $232,000. Hedge funds and other institutional investors own 62.51% of the company's stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.